Mar 1, 2017

Aethlon Medical Announces the Grant of a European Patent Protecting Methods of Quantifying Exosomes

Feb 24, 2017

Aethlon Medical CEO Note: Bill Gates on the Threat of Bioterrorism

Feb 22, 2017

Aethlon Medical Reports Results of Cytomegalovirus, Epstein-Barr and Herpes Simplex Virus Studies

Feb 10, 2017

Aethlon Medical Announces Fiscal 2017 Third Quarter Results

Feb 6, 2017

Aethlon Medical To Host Third Quarter Fiscal 2017 Investor Call On February 10, 2017

Jan 25, 2017

Researchers Announce Plans for Study of Candidate Blood Test to Detect Chronic Traumatic Encephalopathy (CTE) in Former NFL Players

Jan 11, 2017

CEO Note - Clinical Study Update and a Review of 2016 Accomplishments

Dec 21, 2016

Passage of the 21st Century Cures Act and its Potential Implications on Biodefense

Dec 15, 2016

Aethlon Announces Initiation of Sepsis-Related Virus Study

Nov 10, 2016

Aethlon Medical Announces Fiscal 2017 Second Quarter Results